Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes

Nontraditional Markers of Glycemia: Associations with microvascular conditions

(2011) E. Selvin et al.   DIABETES CARE

Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study

(2010) R. Borg et al.   DIABETOLOGIA

Metabolic memory and diabetic retinopathy: Role of inflammatory mediators in retinal pericytes

(2010) Renu A. Kowluru et al.   EXPERIMENTAL EYE RESEARCH

Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications

(2010) Irl B. Hirsch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes

(2009) Jong Chul Won et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial

(2009) J. W. J. Beulens et al.   DIABETOLOGIA

Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

(2008) A. Ceriello et al.   DIABETES

Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients

(2008) C. Stettler et al.   DIABETES CARE

Glycemic Variability: Should we and can we prevent it?

(2008) L. Monnier et al.   DIABETES CARE

Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?

(2008) G. Zoppini et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES